Recent Progress in the Development of New Antimalarial Drugs with Novel Targets
Top Cited Papers
Open Access
- 1 September 2020
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 14, 3875-3889
Abstract
Malaria is a major global health problem that causes significant mortality and morbidity annually. The therapeutic options are scarce and massively challenged by the emergence of resistant parasite strains, which causes a major obstacle to malaria control. To prevent a potential public health emergency, there is an urgent need for new antimalarial drugs, with single-dose cures, broad therapeutic potential, and novel mechanism of action. Antimalarial drug development can follow several approaches ranging from modifications of existing agents to the design of novel agents that act against novel targets. Modern advancement in the biology of the parasite and the availability of the different genomic techniques provide a wide range of novel targets in the development of new therapy. Several promising targets for drug intervention have been revealed in recent years. Therefore, this review focuses on the progress made on the latest scientific and technological advances in the discovery and development of novel antimalarial agents. Among the most interesting antimalarial target proteins currently studied are proteases, protein kinases, Plasmodium sugar transporter inhibitor, aquaporin-3 inhibitor, choline transport inhibitor, dihydroorotate dehydrogenase inhibitor, isoprenoid biosynthesis inhibitor, farnesyltransferase inhibitor and enzymes are involved in lipid metabolism and DNA replication. This review summarizes the novel molecular targets and their inhibitors for antimalarial drug development approaches.Keywords
This publication has 98 references indexed in Scilit:
- Primaquine radical cure of Plasmodium vivax: a critical review of the literatureMalaria Journal, 2012
- Review of pyronaridine anti-malarial properties and product characteristicsMalaria Journal, 2012
- A role for heparan sulfate proteoglycans in Plasmodium falciparum sporozoite invasion of anopheline mosquito salivary glandsBiochemical Journal, 2011
- Malaria Parasite clag3 Genes Determine Channel-Mediated Nutrient Uptake by Infected Red Blood CellsCell, 2011
- The Kennedy phospholipid biosynthesis pathways are refractory to genetic disruption in Plasmodium berghei and therefore appear essential in blood stagesMolecular and Biochemical Parasitology, 2010
- Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data baseMalaria Journal, 2009
- Irreversible effect of cysteine protease inhibitors on the release of malaria parasites from infected erythrocytesCellular Microbiology, 2009
- Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000Transactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferaseMolecular and Biochemical Parasitology, 2007
- Specific Inhibition of the Plasmodial Surface Anion Channel by DantroleneEukaryotic Cell, 2006